Chemistry and Function of Human Plasma Proteins

1980 ◽  
Vol 19 (2) ◽  
pp. 87-99 ◽  
Author(s):  
Hans-Gerhard Schwick ◽  
Heinz Haupt
1998 ◽  
Vol 31 ◽  
pp. S164-S168 ◽  
Author(s):  
Jinshyun R. Wu-Wong ◽  
Douglas B. Dixon ◽  
Terry J. Opgenorth

1975 ◽  
Vol 33 (03) ◽  
pp. 540-546 ◽  
Author(s):  
Robert F Baugh ◽  
James E Brown ◽  
Cecil Hougie

SummaryNormal human plasma contains a component or components which interfere with ristocetin-induced platelet aggregation. Preliminary examination suggests a protein (or proteins) which binds ristocetin and competes more effectively for ristocetin than do the proteins involved in ristocetin-induced platelet aggregation. The presence of this protein in normal human plasma also prevents ristocetin-induced precipitation of plasma proteins at levels of ristocetin necessary to produce platelet aggregation (0.5–2.0 mg/ml). Serum contains an apparent two-fold increase of this component when compared with plasma. Heating serum at 56° for one hour results in an additional 2 to 4 fold increase. The presence of a ristocetin-binding protein in normal human plasma requires that this protein be saturated with ristocetin before ristocetin-induced platelet aggregation will occur. Variations in the ristocetin-binding protein(s) will cause apparent discrepancies in ristocetin-induced platelet aggregation in normal human plasmas.


1992 ◽  
Vol 44 (11) ◽  
pp. 940-942 ◽  
Author(s):  
S. Wanwimolruk ◽  
G. Edwards ◽  
S. A. Ward ◽  
A. M. Breckenridge
Keyword(s):  

2011 ◽  
Vol 285 (5) ◽  
pp. 427-432 ◽  
Author(s):  
Ozren Polašek ◽  
Anne-Louise Leutenegger ◽  
Olga Gornik ◽  
Lina Zgaga ◽  
Ivana Kolcic ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document